Websol Energy System Ltd
₹68.50
+1.35 (2.01%)
Fri, 06 Nov 2026, 03:17 pm
Websol Energy System News
Websol Energy reschedules Q2FY27 earnings call
Websol Energy System Limited has revised its Q2 and H1 FY27 earnings conference call schedule due to technical issues with the original link. The call remains set for November 5, 2026.
03 Nov 2026
companies
Websol appoints Vinay Vyas as CEO of subsidiary
Websol Energy System Ltd appointed Vinay Vyas as CEO of Websol Renewables Pvt Ltd. Vyas brings 18+ years experience in renewable energy and storage.
22 Oct 2026
companies
Websol Energy promoter group releases share encumbrance
Websol Energy System Ltd promoter group released encumbrances on 2.01 crore shares held by IREDA, reducing pledged holdings to 21.92% of capital.
14 Oct 2026
companies
Websol Energy closes trading window for Q2FY27 results
Websol Energy System Ltd closed its trading window from October 1, 2026, until 48 hours after Q2FY27 results declaration to comply with insider trading norms.
28 Sept 2026
companies
Websol secures 54-acre land for 4 GW solar plant
Websol Energy System Limited received a 54.20-acre land allotment in West Bengal for a new 4 GW solar cell and module facility, expanding its manufacturing capacity.
23 Sept 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo